Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Biochemistry ; 47(1): 460-72, 2008 Jan 08.
Article in English | MEDLINE | ID: mdl-18067275

ABSTRACT

Scavenger receptor, class B, type I (SR-BI), controls high-density lipoprotein (HDL) metabolism by mediating cellular selective uptake of lipids from HDL without the concomitant degradation of the lipoprotein particle. We previously identified in a high-throughput chemical screen of intact cells five compounds (BLT-1-5) that inhibit SR-BI-dependent lipid transport from HDL, but do not block HDL binding to SR-BI on the cell surface. Although these BLTs are widely used to examine the diverse functions of SR-BI, their direct target(s), SR-BI itself or some other component of the SR-BI pathway, has not been identified. Here we show that SR-BI in the context of a membrane lipid environment is the target of BLT-1, -3, -4, and -5. The analysis using intact cells and an in vitro system of purified SR-BI reconstituted into liposomes was aided by information derived from structure-activity relationship (SAR) analysis of the most potent of these BLTs, the thiosemicarbazone BLT-1. We found that the sulfur atom of BLT-1 was crucially important for its inhibitory activity, because changing it to an oxygen atom resulted in the isostructural, but essentially inactive, semicarbazone derivative BLT-1sc. SAR analysis also established the importance of BLT-1's hydrophobic tail. BLTs and their corresponding inactive compounds can be used to explore the mechanism and function of SR-BI-mediated selective lipid uptake in diverse mammalian experimental models. Consequently, BLTs may help determine the therapeutic potential of SR-BI-targeted pharmaceutical drugs.


Subject(s)
CD36 Antigens/metabolism , Lipoproteins, HDL/metabolism , Receptors, Lipoprotein/metabolism , Thiosemicarbazones/pharmacology , Amines/chemistry , Amines/pharmacology , Biological Transport/drug effects , Cell Line , Cyclopentanes/chemistry , Cyclopentanes/pharmacology , Humans , Lipid Metabolism/drug effects , Lipoproteins, HDL/antagonists & inhibitors , Liposomes/metabolism , Molecular Structure , Protein Binding/drug effects , Receptors, Lipoprotein/antagonists & inhibitors , Structure-Activity Relationship , Surface Plasmon Resonance , Thiosemicarbazones/chemical synthesis , Thiosemicarbazones/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL